DyslipidemiaNCT07828990
Cardiovascular Risk Factors and Lipid Profile in Hospitalized Mexican Adults
An observational study of Dyslipidemia, run by Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo at 1 site in Mexico.
Trial summary
Traditional cardiovascular risk models are limited in capturing functional alterations in HDL-C linked to smoking and diet in Latin American populations. We analyzed the relationship between traditional and non-traditional risk factors and the serum lipid profile of hospitalized Mexican adults, emphasizing HDL-C… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Dyslipidemia
- How many people
- 107 participants
- Where
- 1 siteMexico
- Study dates
- 13 May 2025to 23 Dec 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Hospitalized mexican adults
Who may be able to join
- Men and women over 18 years of age who are capable of deciding wheter to participate in the study or not.
Who cannot join
- Men and women under 18 years of age, or men and women over 18 years of age who are already under pharmacologic lipid-lowering treatment of any kind.
Trial locations and contacts
1 site in 1 country.
Mexico1 site
Hospital General "Dr. Salvador Zubirán Anchondo"
Chihuahua City, Chihuahua, 31000
About this study
Official title: Traditional and Non-Traditional Cardiovascular Risk Factors Associated With the Lipid Profile of Hospitalized Mexican Adults: A Cross-Sectional Study With Multivariate Analysis and Structural Modeling
Traditional cardiovascular risk models are limited in capturing functional alterations in HDL-C linked to smoking and diet in Latin American populations. We analyzed the relationship between traditional and non-traditional risk factors and the serum lipid profile of hospitalized Mexican adults, emphasizing HDL-C behavior.
Read the detailed description
An analytical, cross-sectional study was conducted in 70 adults following the STROBE statement. Non-parametric tests, Huber's robust multiple regression, and structural equation modeling (SEM) were performed.
- Conditions
- Dyslipidemia
- Keywords
- lipid profile, HDL-cholesterol, Cardiovascular risk factor, diet, Smoking, Mexican population
- Medical subject headings
- Dyslipidemias, Smoking
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Hospitalized adults | Male and female, above 18 years of age, except patients with cognitive impairment or inability to provide informed consent, those with acute conditions that could alter the lipid profile, and those for whom a laboratory sample could not be obtained. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Measure serum lipid profile (total cholesterol, HDL-C, LDL-C, triglycerides, VLDL-C)
Differences in serum lipid concentrations (mg/dL) according to traditional and non-traditional cardiovascular risk factors, with emphasis on HDL-C as an indirect marker of antiatherogenic dysfunction
Measured: Baseline
Secondary outcomes (4)
Measure HDL-C concentration by smoking status
Comparison of HDL-C levels between active smokers and non-smokers
Measured: Baseline
Measure Triglyceride and VLDL-C levels in patients with diabetes mellitus
Comparison of triglyceride and VLDL-C concentrations by diabetes mellitus diagnosis
Measured: Baseline
Measure HDL-C levels by ultraprocessed beverage consumption
Association between self-reported ultraprocessed beverage intake and HDL-C concentration
Measured: Baseline
Identify anthropometric predictors of lipid profile
Contribution of weight, height, and BMI to each lipid variable via multiple regression and structural equation models
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Sep 2026
- Study start13 May 2025
- Primary completion30 Nov 2025
- Study completion23 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DyslipidemiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 107 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo
- Sponsor type
- Other government
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07828990
- Sponsor's protocol ID
- 0402/2025
- Status last verified
- May 2026
- First submitted
- 26 May 2026
- Last updated
- 18 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Traditional and Non-Traditional Cardiovascular Risk Factors Associated With the Lipid Profile of Hospitalized Mexican Adults: A Cross-Sectional Study With Multivariate Analysis and Structural Modeling
- ClinicalTrials.gov ID
- NCT07828990
- Acronym / sponsor ID
- 0402/2025
- Conditions
- Dyslipidemia
- Keywords
- lipid profile, HDL-cholesterol, Cardiovascular risk factor, diet, Smoking, Mexican population
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 107 participants (actual)
- Lead sponsor
- Hospital General de Chihuahua - Dr. Salvador Zubirán AnchondoOther government
- Study start
- 13 May 2025 (actual)
- Primary completion
- 30 Nov 2025 (actual)
- Study completion
- 23 Dec 2025 (actual)
- First posted
- 18 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Traditional cardiovascular risk models are limited in capturing functional alterations in HDL-C linked to smoking and diet in Latin American populations. We analyzed the relationship between traditional and non-traditional risk factors and the serum lipid profile of hospitalized Mexican adults, emphasizing HDL-C behavior.
Detailed description
An analytical, cross-sectional study was conducted in 70 adults following the STROBE statement. Non-parametric tests, Huber's robust multiple regression, and structural equation modeling (SEM) were performed.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Hospitalized adults | – | –Male and female, above 18 years of age, except patients with cognitive impairment or inability to provide informed consent, those with acute conditions that could alter the lipid profile, and those for whom a laboratory sample could not be obtained. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Hospitalized mexican adults
Key inclusion criteria (1 listed)
- Men and women over 18 years of age who are capable of deciding wheter to participate in the study or not.
Key exclusion criteria (1 listed)
- Men and women under 18 years of age, or men and women over 18 years of age who are already under pharmacologic lipid-lowering treatment of any kind.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Measure serum lipid profile (total cholesterol, HDL-C, LDL-C, triglycerides, VLDL-C)
Time frame: Baseline
Differences in serum lipid concentrations (mg/dL) according to traditional and non-traditional cardiovascular risk factors, with emphasis on HDL-C as an indirect marker of antiatherogenic dysfunction
4 secondary outcomes
Measure HDL-C concentration by smoking status
Time frame: Baseline
Measure Triglyceride and VLDL-C levels in patients with diabetes mellitus
Time frame: Baseline
Measure HDL-C levels by ultraprocessed beverage consumption
Time frame: Baseline
Identify anthropometric predictors of lipid profile
Time frame: Baseline
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for Dyslipidemia
Active, not recruitingObservational study
Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
Primary Hypercholesterolemia, Mixed Dyslipidemia
Not yet recruiting
Plasma Lipids-Dependent Vitamin E Metabolism During Dynamic Hyperlipidemia
Lipid Metabolism Disorders
Active, not recruitingObservational study
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
Hypertension, Diabetes
Active, not recruiting
Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT)
Cardiovascular Diseases, Hypertension
Active, not recruitingPhase 3
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Primary Prevention of Atherosclerotic Cardiovascular Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Dyslipidemia, run by Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo at 1 site in Mexico.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Mexico. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Measure serum lipid profile (total cholesterol, HDL-C, LDL-C, triglycerides, VLDL-C) (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2026.